Next-generation obesity drug Retatrutide is being developed by pharmaceutical giant Eli Lilly, which also makes tirzepatide, a potent dual-acting treatment […]
Category: eli lilly
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
The patient was not recommended for bariatric surgery, given their age and other conditions. It was unclear whether the person […]
Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
Skip to content The interim Phase I trial data was only from 35 people, but results look good so far. […]